Written by Jen Finn
December 20, 2012
As president, Barack Obama promised to change "the posture of our federal government from being one of the most anti-science administrations in American history to one that embraces science and technology." To publicly guarantee that, the White House issued a science integrity memorandum in 2009 pledging, "Political officials should not suppress or alter scientific or technological findings and conclusions."
Except, it appears, when it comes to the fate of the first transgenic animal to be considered for federal approval—a genetically modified (GM) salmon developed by AquaBounty Technologies of Massachusetts. The so-called AquAdvantage salmon is a fish that has been modified to grow to market size in about half the usual time. It's raised in contained structures that eliminate many of the environmental effects that make farmed salmon unpopular with some environmentalists, including the generation of excess waste and the potential to spread disease or escape and compete with wild salmon.
The bioengineered salmon has been winding its way through a labyrinthine approval process for 17 years. And it's been in regulatory purgatory for more than two years since the Food and Drug Administration held public hearings—and promised a final determination within weeks.
As recently as last week, a spokeswoman for the Food and Drug Administration told me, "The application is still under review." But that's not the whole story.
Read the full story at Slate>>
It’s no secret that fraud is a problem in the seafood industry. Oceana repeatedly touts a mislabeling epidemic. While their method has been criticized, the perception of rampant fraud has been established.Read more ...
The Center for Coastal Studies recently announced that Owen Nichols, Director of the Center for Coastal Studies’ Marine Fisheries Research Program, has been selected as this year’s recipient of the John Annala Fishery Leadership Award by the Gulf of Maine Research Institute.Read more ...